Oncology Institute, Inc. TOI 深 沪
交易中 03-25 10:16:15 美东时间
3.24
+0.110
+3.51%
华盛通- 最 高3.47
- 今 开3.19
- 成交量 49.62万股
- 最 低 3.19
- 昨 收 3.13
- 总市值 3.19亿
- 52周最高 4.88
- 市盈率 静 --
- 换手率 0.50%
- 52周最低 1.14
- 委 比 -67.21%
- 总股本 9838.13万
- 历史最高 12.66
- 量 比 2.74
- 振 幅 8.95%
- 历史最低 0.1253
- 每 手 1
- 风险率 0.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | Eightco获Bitmine、木头姐巨额注资！稀土概念美国锑业单日大涨逾19%
Eightco单日飙涨34%，获Bitmine、木头姐巨额注资！稀土概念美国锑业大涨逾19%，五角大楼签署9600万美元稀土供应框架>>
03-17 18:53
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares moved upwards by 70.7% to $0.38 during ...
03-13 05:05
The Oncology Institute shares are trading higher after the company reported better-than-expected Q4 financial results.
The Oncology Institute shares are trading higher after the company reported bet...
03-13 04:43
Oncology Institute Affirms FY2026 Sales Guidance of $630.000M-$650.000M.
Oncology Institute (NASDAQ:TOI) affirms FY2026 sales outlook from $630.000 million-$650.000 million to $630.000 million-$650.000 million.
03-13 04:08
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
BTIG Reiterates Buy on Oncology Institute, Maintains $7 Price Target
BTIG analyst David Larsen reiterates Oncology Institute (NASDAQ:TOI) with a Buy and maintains $7 price target.
03-09 17:55
The Oncology Institute Projects 2026 Revenue to Hit $650M
The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary 2026 outlook.2026
01-12 21:07
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
